These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1370 related items for PubMed ID: 15378187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.
    Jani AB, Schreibmann E, Rossi PJ, Shelton J, Godette K, Nieh P, Master VA, Kucuk O, Goodman M, Halkar R, Cooper S, Chen Z, Schuster DM.
    J Nucl Med; 2017 Mar; 58(3):412-418. PubMed ID: 27609792
    [Abstract] [Full Text] [Related]

  • 7. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S, Mathai M, Cui J, Purdy JA, Valicenti RK.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1897-902. PubMed ID: 21536391
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging in postprostatectomy radiotherapy planning.
    Sefrova J, Odrazka K, Paluska P, Belobradek Z, Brodak M, Dolezel M, Prosvic P, Macingova Z, Vosmik M, Hoffmann P, Louda M, Nejedla A.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):911-8. PubMed ID: 21420244
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M, Brannath W, Brückner M, Wagner D, Kaltenborn A, Temme N, Hermann RM.
    Br J Radiol; 2017 Feb 01; 90(1070):20160370. PubMed ID: 27936891
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L, Armstrong J, Buckney S, Assiri M, Cannon M, Holmberg O.
    Radiother Oncol; 2008 Jul 01; 88(1):61-6. PubMed ID: 18453021
    [Abstract] [Full Text] [Related]

  • 18. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
    Croke J, Maclean J, Nyiri B, Li Y, Malone K, Avruch L, Kayser C, Malone S.
    Radiat Oncol; 2014 Dec 23; 9():303. PubMed ID: 25534278
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.